YBX1 promotes MSC osteogenic differentiation by activating the PI3K/AKT pathway

CONCLUSION: Our study provides a new target and theoretical basis for the treatment of bone diseases.PMID:35929633 | DOI:10.2174/1574888X17666220805143833

Source: Current Stem Cell Research and Therapy - August 5, 2022 Category: Stem Cells Authors: Jiayu Chen Zhanliang Liu Huicheng Zhang Yongqian Yang Huangxiang Zeng Rongwei Zhong Shangdao Lai Hongxing Liao Source Type: research